Bioclinic Canada Niacin 250 mg (Vitamin B3) Tablet
Bioclinic Canada Niacin 250 mg (Vitamin B3) Tablet, NPN 80016658: natural health product licensed in Canada. Medicinal ingredients: Acide 3-pyridinecarboxylique.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 3-pyridinecarboxylique Source : Niacine | 250 mg | Not calculated |
Non-medicinal ingredients
Dihydrate dibasique de phosphate de calcium, Stéarate de magnésium, Dioxyde de silicium, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Helps normal growth and development. Helps the body to metabolize carbohydrates. Helps the body to metabolize fats. Helps the body to metabolize proteins. Helps to prevent niacin deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Product record
- Licence holder
- Bioclinic Canada
- NPN or DIN-HM
- 80016658
- Status
- Active licence
- Licence date
- 12 March 2010
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80016658
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Bioclinic Canada Niacin 250 mg (Vitamin B3) Tablet: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80016658-bioclinic-canada-niacin-250-mg-vitamin-b3-tablet, updated 12 March 2010.